Ebola Viral Infections - Pipeline Review, H1 2014

The Report Ebola Viral Infections - Pipeline Review, H1 2014 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz


Albany, NY -- (SBWire) -- 11/10/2014 --Ebola Viral Infections Pipeline Review, H1 2014, provides an overview of the Ebola Viral Infectionss therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Ebola Viral Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Ebola Viral Infections and special features on late-stage and discontinued projects.

View Full Report

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

Download Detail Report With Complete TOC

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Explore All Latest Published Reports By Global Markets Direct


* The report provides a snapshot of the global therapeutic landscape of Ebola Viral Infections

* The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

* The report reviews key players involved in the therapeutics development for Ebola Viral Infections and enlists all their major and minor projects

* The report summarizes all the dormant and discontinued pipeline projects

* A review of the Ebola Viral Infections products under development by companies and universities/research institutes based on information derived from company and industry-specific sources

* Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages

* A detailed assessment of monotherapy and combination therapy pipeline projects

* Coverage of the Ebola Viral Infections pipeline on the basis of target, MoA, route of administration and molecule type

* Latest news and deals relating related to pipeline products

Reasons to buy:

* Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies

* Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

* Develop strategic initiatives by understanding the focus areas of leading companies

* Identify and understand important and diverse types of therapeutics under development for Ebola Viral Infections

* Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

* Devise corrective measures for pipeline projects by understanding Ebola Viral Infections pipeline depth and focus of Indication therapeutics

* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Related Reports

Global IVIG Industry 2014 Market Research Report

View Full Report

The report firstly introduced IVIG basic information included IVIG definition classification application industry chain structure industry overview;

Then introduce North America (United States Canada Mexico etc) Europe (Germany France United Kingdom Italy Spain etc) Asia (China Japan India Korea etc) Rest of World (Australia South America Middle East and Africa etc) Key players 2009-2014 IVIG Capacity Production Price Cost Gross Production Value Gross Margin etc Data and information.

Download Detail Report With Complete TOC

And the report also listed North America Europe Asia Rest of World regional 2009-2014 IVIG consumption and different regions trading business and regional import export and location regions consumption, and also listed global total data.

Research and Development Prospect of China Dialysis Market, 2014-2018

View Full Report

Based on the 2013 version, this update Report provides detailed analysis on Chinese government policies about dialysis industry and the relevant effect in recent three years, and conducts in-depth research about dialysis industry segmentations. Moreover, it analyzes Chinese private-owned hemodialysis services. In the aspect of enterprises, this update Report not only updates the latest information about the key enterprises listed in 2013 version, but also adds the information about some enterprises who intend to enter into this industry. This update Report reflects an overall development situation of Chinas dialysis industry and provides references for investors and entrepreneurs.

Download Detail Report With Complete TOC

In China, hemodialysis treatment has gained a wide popularity. By the end of 2013, the number of dialysis centers has amounted to 3637, contributing a make scale of CNY 14.4 billion, in which, hemodialysis was CNY 11.5 billion, and peritoneal dialysis was CNY 2.9 billion.

About Marketresearchreports.biz
Marketresearchreports.biz is the most comprehensive collection of market research reports. Marketresearchreports.biz services are especially designed to save time and money of our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Browse Blog

Media Relations Contact

Sheela AK
Business Head
Market Research Reports.biz

View this press release online at: http://rwire.com/560693